Why Tenet Healthcare Shares Are Surging Today

Comments
Loading...
  • Tenet Healthcare Corp's THC shares are gaining Tuesday morning following its Street-beating first quarter FY23 performance and raised FY23 outlook.
  • THC Q1 FY23 adjusted EPS came in at $1.42, down from $1.90 a year ago and beating the consensus of $1.15.
  • The net operating revenue of the multinational healthcare services company reached $5.02 billion, up 5.8% Y/Y, beating the consensus of $4.85 billion.
  • Hospital segment sales rose 2.7% to $3.89 billion due to increased adjusted admissions, partially offset by lower COVID-related volume and acuity.
  • Ambulatory segment revenues increased 22.6% to $905 million, driven by same-facility solid net surgical case growth, acquisitions and opening of new facilities, service line growth, and improved pricing yield.
  • Conifer Segment sales were majorly flat on year to $324 million. 
  • Adjusted EBITDA slumped 6.3% to $832 million from $888 million a year ago.
  • Net income reached $143 million, up from $139 million last year.
  • Outlook: Tenet forecasts Q2 FY23 sales of $4.8 billion - $5 billion (consensus $4.91 billion).
  • It expects an adjusted EPS of $1.07 - $1.30 (consensus $1.16).
  • For FY23, the company raised its sales guidance from $19.70 billion - $20.10 billion to $19.80 billion - $20.20 billion versus the Street view of $20.04 billion.
  • THC raised its adjusted EPS forecast from $4.68 - $5.85 to $4.92 - $6.09, against the consensus of $5.43.
  • Price Action: THC shares are 5.5% higher at $72.81 during the premarket trading session on Tuesday.
THC Logo
THCTenet Healthcare Corp
$123.79-2.93%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
81.13
Growth
82.72
Quality
-
Value
41.99
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: